Rationalization of the effects of mutations on peptide and protein aggregation rates

Nature

Volumn 424, Issue 6950, 2003, Pages 805-808

  Chiti, Fabrizio ^a,b   Stefani, Massimo ^b   Taddei, Niccolò ^b   Ramponi, Giampietro ^b   Dobson, Christopher M ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b UNIVERSITY OF FLORENCE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

PATHOGENIC EFFECTS;

AGGLOMERATION; HYDROPHOBICITY; PATHOLOGY;

PROTEINS;

AMYLOID; PEPTIDE; POLYPEPTIDE; PROTEIN;

BIOLOGY; PROTEIN;

ALZHEIMER DISEASE; ARTICLE; HYDROPHOBICITY; MUTATION; PARKINSON DISEASE; PATHOGENESIS; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN FOLDING; PROTEIN SECONDARY STRUCTURE; AMYLOIDOSIS; CHEMISTRY; ELECTRICITY; GENETICS; KINETICS; METABOLISM; POINT MUTATION; PROTEIN DENATURATION; SENILE PLAQUE; THERMODYNAMICS;

AMYLOIDOSIS; ELECTROSTATICS; HYDROPHOBICITY; KINETICS; PEPTIDES; POINT MUTATION; PROTEIN DENATURATION; PROTEIN FOLDING; PROTEIN STRUCTURE, SECONDARY; PROTEINS; SENILE PLAQUES; THERMODYNAMICS;

EID: 0042467550     PISSN: 00280836     EISSN: None     Source Type: Journal    
DOI: 10.1038/nature01891     Document Type: Article

References (30)

1. Kopito, R. R. Aggresomes, inclusion bodies and protein aggregation. Trends Cell Biol. 10, 524-530 (2000).
2. Kelly, J. W. The alternative conformations of amyloidogenic proteins and their multi-step assembly pathways. Curr. Opin. Struct. Biol. 8, 101-106 (1998).
3. Rochet, J. C. & Lansbury, P. T. Jr Amyloid fibrillogenesis: Themes and variations. Curr. Opin. Struct. Biol. 10, 60-68 (2000).
4. Carriò, M. M. & Villaverde, A. Construction and deconstruction of bacterial inclusion bodies. J. Biotech. 96, 3-12 (2002).
5. Dobson, C. M. Protein misfolding, evolution and disease. Trends Biochem. Sci. 24, 329-332 (1999).
6. Sunde, M. & Blake, C. The structure of amyloid fibrils by electron microscopy and X-ray diffraction. Adv. Protein Chem. 50, 123-159 (1997).
7. Liemann, S. & Glockshuber, R. Influence of amino acid substitutions related to inherited human prion diseases on the thermodynamic stability of the cellular prion protein. Biochemistry 38, 3258-3267 (1999).
8. Hammarstrom, P., Wiseman, R. L., Powers, E. T. & Kelly, J. W. Prevention of transthyretin amyloid disease by changing protein misfolding energetics. Science 299, 713-716 (2003).
9. Chiti, F. et al. Kinetic partitioning of protein folding and aggregation. Nature Struct. Biol. 9, 137-143 (2002).
10. Chiti, F. et al. Studies of the aggregation of mutant proteins in vitro provide insights into the genetics of amyloid diseases. Proc. Natl Acad. Sci. USA 99, 16419-16426 (2002).
11. Dobson, C. M. Getting out of shape. Nature 418, 729-730 (2002).
12. Giasson, B. I., Murray, I. V., Trojanowski, J. Q. & Lee, V. M. A hydrophobic stretch of 12 amino acid residues in the middle of α-synuclein is essential for filament assembly. J. Biol. Chem. 276, 2380-2386 (2001).
13. Azriel, R. & Gazit, E. Analysis of the minimal amyloid-forming fragment of the islet amyloid polypeptide. An experimental support for the key role of the phenylalanine residue in amyloid formation. J. Biol. Chem. 276, 34156-34161 (2001).
14. Sakagashira, S. et al. S20G mutant amylin exhibits increased in vitro amyloidogenicity and increased intracellular cytotoxicity compared to wild-type amylin. Am. J. Pathol. 157, 2101-2109 (2000).
15. Salmona, M. et al. Molecular determinants of the physicochemical properties of a critical prion protein region comprising residues 106-126. Biochem. J. 342, 207-214 (1999).
16. Thompson, A. J., Barnham, K. J., Norton, R. S. & Barrow, C. J. The Val-210-Ile pathogenic Creutzfeldt-Jakob disease mutation increases both the helical and aggregation propensities of a sequence corresponding to helix-3 of PrP(C). Biochim. Biophys. Acta 1544, 242-254 (2001).
17. Conway, K. A. et al. Acceleration of oligomerization, not fibrillization, is a shared property of both alpha-synuclein mutations linked to early-onset Parkinson's disease: Implications for pathogenesis and therapy. Proc. Natl Acad. Sci. USA 97, 571-576 (2000).
18. Van Nostrand, W. E., Melchor, J. P., Cho, H. S., Greenberg, S. M. & Rebeck, G. W. Pathogenic effects of D23N Iowa mutant amyloid β-protein. J. Biol. Chem. 276, 32860-32866 (2001).
19. Miravalle, L. et al. Substitutions at codon 22 of Alzheimer's abeta peptide induce diverse conformational changes and apoptotic effects in human cerebral endothelial cells. J. Biol. Chem. 275, 27110-27116 (2000).
20. Nilsberth, C. et al. The 'Arctic' APP mutation (E693G) causes Alzheimer's disease by enhanced Aβ protofibril formation. Nature Neurosci. 4, 887-893 (2001).
21. Esler, W. P. et al. Point substitution in the central hydrophobic cluster of a human β-amyloid congener disrupts peptide folding and abolishes plaque competence. Biochemistry 35, 13914-13921 (1996).
22. Gamblin, T. C., Berry, R. W. & Binder, L. I. Tau polymerization: Role of the amino terminus. Biochemistry 42, 2252-2257 (2003).
23. Barghorn, S. et al. Structure, microtubule interactions, and paired helical filament aggregation by tau mutants of frontotemporal dementias. Biochemistry 39, 11714-11721 (2000).
24. Gamblin, T. C. et al. In vitro polymerization of tau protein monitored by laser light scattering: Method and application to the study of FTDP-17 mutants. Biochemistry 39, 6136-6144 (2000).
25. Nacharaju, P. et al. Accelerated filament formation from tau protein with specific FTDP-17 missense mutations. FEBS Lett. 447, 195-199 (1999).
26. Li, L., Von Bergen, M., Mandelkow, E. M. & Mandelkow, E. Structure, stability, and aggregation of paired helical filaments from tau protein and FTDP-17 mutants probed by tryptophan scanning mutagenesis. J. Biol. Chem. 277, 41390-41400 (2002).
27. Symmons, M. F., Buchanan, S. G., Clarke, D. T., Jones, G. & Gay, N. J. X-ray diffraction and far-UV CD studies of filaments formed by a leucine-rich repeat peptide: Structural similarity to the amyloid fibrils of prions and Alzheimer's disease β-protein. FEBS Lett. 412, 397-403 (1997).
28. Orpiszewski, J. & Benson, M. D. Induction of beta-sheet structure in amyloidogenic peptides by neutralization of aspartate: A model for amyloid nucleation. J. Mol. Biol. 289, 413-428 (1999).
29. Street, A. G. & Mayo, S. L. Intrinsic β-sheet propensities result from van der Waals interactions between side chains and the local backbone. Proc. Natl Acad. Sci. USA 96, 9074-9076 (1999).
30. Bucciantini, M. et al. Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases. Nature 416, 507-511 (2002).